河南东吉高科有限公司
标准物质
| DLM-7061E | Benzoic acid calibrant for qNMR 15mM benzoic acid in DMSO-D₆ (120 μL fill volume) | - |
| DLM-7087 | 5% Chloroform + 0.2% Cr(acac)₃ in acetone-D₆ (D, 99.9%) | - |
| DLM-7092-PK | 2mM DSS-D₆ + 80mM potassium phosphate buffer in deuterium oxide (D, 99.96%) | - |
| DLM-7101-0.005 | MELATONIN | 5MG |
| DLM-7101-0.01 | MELATONIN | 10MG |
| DLM-710-100 | AMMONIUM DEUTEROXIDE-D5 | 100GOFS |
| DLM-710-50 | AMMONIUM DEUTEROXIDE-D5 | 50GOFS |
| DLM-7116-1.2 | DIURON | 1.2ML |
| DLM-7136-1.2 | TRIBUTYLTIN CHLORIDE | 1.2ML |
| DLM-7141-1.2 | PROPOXUR | 1.2ML |
| DLM-7150-1.2 | OXYDEMETON-METHYL (95% CHEMICAL PURITY) | 1.2ML |
| DLM-7151-1.2 | DIMETHOATE | 1.2ML |
| DLM-7152-1.2 | BENSULIDE | 1.2ML |
| DLM-7153-1.2 | CHLORPYRIFOS-METHYL | 1.2ML |
| DLM-7170-1.2 | 1-AMINOHYDANTOIN HYDROCHLORIDE (AHD) | 1.2ML |
| DLM-7171-1.2 | 3-AMINO-2-OXAZOLIDONE (AOZ) | 1.2ML |
| DLM-7172-1.2 | 5-(4-MORPHOLINYLMETHYL)-3-AMINO-2-OXAZOLIDINONE | 1.2ML |
| DLM-72 | 40% -Dioxane in benzene-D₆ (528 PP tube) | - |
| DLM-7202-1 | L-LEUCINE-N-FMOC | 1G |
| DLM-7206-PK | 17α-Hydroxypregnenolone (21,21,21-D₃, 97%) | - |
| DLM-7209-0.005 | 11-DEOXYCORTISOL | 5MG |
| DLM-7209-0.01 | 11-DEOXYCORTISOL | 0.01G |
| DLM-7228-PK | 11-Deoxycorticosterone (DOC) (2,2,4,6,6,17,21,21-D₈, 96%) CP 97% | - |
| DLM-7248-PK | Glycine, -hexanoyl (2,2,-D₂, 98%) | - |
| DLM-7249-0.05 | IODOACETAMIDE | 0.05G |
| DLM-7249-0.1 | IODOACETAMIDE | 0.1G |
| DLM-7260-PK | Cholesterol (25,26,26,26-D₄, 98%) | - |
| DLM-72A | 40% -Dioxane in benzene-D₆ | - |
| DLM-72-TW | 40% -Dioxane in benzene-D₆ (545PPT-8) thin wall | - |
| DLM-7302-PK | Tetracosanoic acid (D₄₇, 98%) | - |
| DLM-7316-1 | L-ALANINE-N-FMOC | 1G |
| DLM-7326-PK | D-Alanine (D₇, 98%) <5% L | - |
| DLM-7332-PK | Poly(ethylene glycol) (ethylene-D₄, 98%) dihydroxy terminated | - |
| DLM-733-5 | BENZENE | 5G |
| DLM-7339-1 | GLYCINE-N-FMOC | 1G |
| DLM-734-1 | ACETANILIDE | 1G |
| DLM-7347-0.01 | CORTICOSTERONE | 0.01G |
| DLM-7364-1 | SODIUM CYANOBORODEUTERIDE | 1G |
| DLM-7364-5 | SODIUM CYANOBORODEUTERIDE | 5G |
| DLM-738-0.5 | N-DODECANOL | 0.5G |
| DLM-738-1 | N-DODECANOL | 1G |
| DLM-740-1-BS | ETHYLENE | 1L |
| DLM-740-1-LB | ETHYLENE | 1L |
| DLM-743-5 | FORMIC ACID | 5G |
| DLM-7456-PK | Sodium estrone 3-sulfate (2,4,16,16-D₄, 98%) stabilized with 50% w/w Tris | - |
| DLM-7457-PK | Sodium 17β-estradiol 3-sulfate (2,4,16,16-D₄, 98%) stabilized with 50% w/w Tris | - |
| DLM-7471-50 | 3-METHYLADENINE | 50MG |
| DLM-7472-0.01 | 7-METHYLGUANINE | 0.01G |
| DLM-7473-0.01 | 6-O-METHYLGUANINE | 0.01G |
| DLM-7476-5 | ADMA:HCL:XH2O (MAY BE HYDRATE) (ASYMMETRIC | 5MG |
| DLM-7476-MG-PK | Asymmetric dimethylarginine (ADMA)·HCl·xH₂O (2,3,3,4,4,5,5-D₇, 98%) may be hydrate | - |
| DLM-7487-PK | Myristic acid (13,13,14,14,14-D₅, 98%) | - |
| DLM-7490-PK | Nonanoic acid (9,9,9-D₃, 98%) | - |
| DLM-7504-MG-PK | Dexamethasone (4,6α,21,21-D₄, 96%) may contain D at C-2 | - |
| DLM-7504-PK | Dexamethasone (4,6α,21,21-D₄, 96%) may contain D at C-2 | - |
| DLM-7506-PK | 2,4,6-Tribromophenol (3,5-D₂, 98%) | - |
| DLM-7507-SL-10 | 2-Deoxyadenosine 5′-triphosphate, lithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7507-SL-50 | 2-Deoxyadenosine 5′-triphosphate, lithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7508-SL-10 | 2-Deoxycytidine 5′-triphosphate, dilithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7508-SL-50 | 2-Deoxycytidine 5′-triphosphate, dilithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7509-SL-10 | 2-Deoxyguanosine 5′-triphosphate, dilithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7509-SL-50 | 2-Deoxyguanosine 5′-triphosphate, dilithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7-50S | Chloroform-D (D, 99.8%) + silver foil | - |
| DLM-7510-SL-10 | Thymidine 5′-triphosphate, lithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7510-SL-50 | Thymidine 5′-triphosphate, lithium salt (U-D, 97%) CP 90% (in solution) | - |
| DLM-7511-SL-4X10 | Set Of 4 2′-deoxyribonucleoside 5′-triphosphates (U-D, 98%) CP 90% (LI salts/IN solution) | - |
| DLM-7511-SL-4X50 | Set Of 4 2′-deoxyribonucleoside 5′-triphosphates (U-D, 98%) CP 90% (LI salts/IN solution) | - |
| DLM-7514-CA | ADENOSINE 5′-TRIPHOSPHATE (ATP), AMMONIUM SALT | 100UMOL |
| DLM-7514-CA-20 | ADENOSINE 5′-TRIPHOSPHATE (ATP), AMMONIUM SALT | 20UMOL |
| DLM-7514-CA-50 | ADENOSINE 5′-TRIPHOSPHATE (ATP), AMMONIUM SALT | 50UMOL |
| DLM-7515-CA | CYTIDINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 100UMOL |
| DLM-7515-CA-20 | CYTIDINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 20UMOL |
| DLM-7515-CA-50 | CYTIDINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 50UMOL |
| DLM-7516-CA | GUANOSINE 5′-TRIPHOSPHATE (GTP), AMMONIUM | 100UMOL |
| DLM-7516-CA-20 | GUANOSINE 5′-TRIPHOSPHATE (GTP), AMMONIUM | 20UMOL |
| DLM-7516-CA-50 | GUANOSINE 5′-TRIPHOSPHATE (GTP), AMMONIUM | 50UMOL |
| DLM-7517-CA | URIDINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 100UMOL |
| DLM-7517-CA-20 | URIDINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 20UMOL |
| DLM-7517-CA-50 | URIDINE 5′-TRIPHOSPHATE, AMMONIUM SALT | 50UMOL |
| DLM-7518-CA | SET OF 4 RIBONUCLEOSIDE 5′-TRIPHOSPHATES | 4X100UMOL |
| DLM-7518-CA-4X20 | SET OF 4 RIBONUCLEOSIDE 5′-TRIPHOSPHATES | 4X20UMOL |
| DLM-7518-CA-4X50 | SET OF 4 RIBONUCLEOSIDE 5′-TRIPHOSPHATES | 4X50UMOL |
| DLM-7518-SL-4X10 | Set Of 4 2′-ribonucleoside 5′-triphosphates (U-D, 98%) CP 90% (LI salts/IN solution) | - |
| DLM-7518-SL-4X50 | Set Of 4 2′-ribonucleoside 5′-triphosphates (U-D, 98%) CP 90% (LI salts/IN solution) | - |
| DLM-7521-0.1 | 2-HYDROXYBENZOIC ACID (SALICYLIC ACID) | 0.1G |
| DLM-7521-0.25 | 2-HYDROXYBENZOIC ACID (SALICYLIC ACID) | 0.25G |
| DLM-754-0.05 | L-CARNITINE:HCL, O-ACETYL | 0.05G |
| DLM-755-0.01 | L-CARNITINE:HCL, O-OCTANOYL | 0.01G |
| DLM-7562-1 | 3-(Trimethylsilyl)propionic acid (2,2,3,3-D₄, carboxyl-D, 98%) | - |
| DLM-7575-0.25 | L-LEUCINE-N-FMOC | 0.25G |
| DLM-76 | 1% Chloroform in acetone-D₆ | - |
| DLM-7616-PK | Sodium butyrate (D₇, 98%) | - |
| DLM-7630-0.5 | N-ISOPROPYLACRYLAMIDE | 0.5G |
| DLM-7654-1 | FUMARIC ACID | 1G |
| DLM-7663-MG-PK | Triethanolamine (D₁₅, 98%) CP 97% | - |
| DLM-7663-PK | Triethanolamine (D₁₅, 98%) CP 97% | - |
| DLM-766-PK | Linoleic acid (18:2), ethyl ester (D₃₁, 98%) CP 95% | - |
| DLM-767-25 | N-PROPANOL | 25G |
| DLM-769-0.1 | L-CYSTEINE | 0.1G |
| DLM-7693-PK | Uridine (ribose-5,5-D₂, 98%) | - |